“…Several bis-benzimidazoles have shown significant antibacterial activities against drug-resistant bacteria (methicillin-resistant Staphylococcus aureus -MRSA and methicillin resistant S. epidermidis -MRSE and vancomycin resistant enterococci -VRE strains) [19,37]. In addition, diamidine derivatives of bis-indoles, as structural analogues of benzimidazoles, were shown to exhibit in vitro activity against a broad spectrum of Gramnegative and Gram-positive pathogens such as S. aureus (including MRSA) and E. faecalis (including VRE) which additionally supports the use of mono-and bis-benzimidazole units in 3,4-ethylenedioxythiophene series [21,24].…”